Realbotix unit secures up to USD 5 million unsecured bridge loan from Onconetix
ONCO•Bridge loan facility tied to proposed merger
Realbotix entered an unsecured bridge loan facility with Onconetix tied to the proposed merger announced Feb. 12, 2026.
The facility uses an unsecured promissory note with an initial draw of USD 2.5 million, expandable to USD 5 million.
The note is non-interest bearing, with automatic cancellation at merger closing without repayment by the borrower or guarantor.
Termination of the merger triggers 12% annual interest on outstanding principal from the termination date.
Realbotix guarantees payment under the note, with a covenant limiting additional indebtedness without Onconetix consent.
